Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-04-05
2005-04-05
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S365000, C514S381000, C514S397000, C514S406000, C514S422000, C514S428000, C546S208000, C546S276400, C548S204000, C548S253000, C548S314700, C548S364100, C548S517000, C548S527000, C548S548000, C548S567000
Reexamination Certificate
active
06875776
ABSTRACT:
The present application describes modulators of CCR3 of formula (I):or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
REFERENCES:
patent: 3988294 (1976-10-01), Hill
patent: 5001134 (1991-03-01), Depin et al.
patent: 5236921 (1993-08-01), Emonds-Ai et al.
patent: 5317020 (1994-05-01), Emonds-Ai et al.
patent: 6331541 (2001-12-01), Ko et al.
patent: 6331545 (2001-12-01), Ko et al.
patent: 6441001 (2002-08-01), Watson et al.
patent: 6444686 (2002-09-01), Ko et al.
patent: 6492400 (2002-12-01), Ko et al.
patent: 6521592 (2003-02-01), Ko et al.
patent: 0747357 (1996-12-01), None
patent: 0903349 (1999-03-01), None
patent: 1261383 (1989-10-01), None
patent: 9320099 (1993-10-01), None
patent: 9422846 (1994-10-01), None
patent: 9427991 (1994-12-01), None
patent: 9519344 (1995-07-01), None
patent: 9717954 (1997-05-01), None
patent: 9719060 (1997-05-01), None
patent: 9722597 (1997-07-01), None
patent: 9727752 (1997-08-01), None
patent: 9738665 (1997-10-01), None
patent: 9825604 (1998-06-01), None
patent: 9825617 (1998-06-01), None
patent: 9831364 (1998-07-01), None
patent: 9904794 (1999-02-01), None
patent: WO 0029377 (2000-05-01), None
Bremner et al., Therapy of Crohn's Disease in childhood, Expert Opin. Pharmacother. 3(7):809-825, 2002.*
Havlioglu et al., Slit proteins, potential endogenous modulators of inflammation, Journal of Neurovirology, 8486-495, 2002.*
Beers et al., Crohn's Disease, Ulcerative colitis, Psoriasis, The Merck Manual of Diagnosis and Therapy, Seventeenth Edition (online), 1999.*
Singh et al., Immune Therapy in inflammatory bowel disease and models of colitis, British Journal of Surgery, 88: 1558-69, 2001.*
Robinson, Medical Therapy of Inflammatory Bowel Disease for the 21st Century, Eur. J. Surg. Suppl. 582:90-98, 1998.*
Kim et al., “Migration and proliferation of guinea pig and human airway epithelial cells in response to tachykinins”, Am.J.Physiol., 1995, vol. 269, pp. L119-L126, Chem. Abstract No. 123:133809.
Kraneveld et al., Airway hyperresponsiveness; first eosinophils and then neuropeptides., Int. J. Immunopharm., 1996, vol. 19, 9/10, pp. 519-528, Chem. Abstract No. 129:107602.
Holladay et al., “Amino Acid-Derived Piperidides as Novel CCK8Ligands with Anxiolytic-Like Properties”,Bioorganic&Medicinal Chemistry Letters, vol. 5, No. 24, pp. 3057-3062, 1995.
Clark Cheryl McArdle
DeLucca George V.
Duncia John V.
Ko Soo S.
Santella III Joseph B.
Bristol-Myers Squibb Pharma Company
Rao Deepak
VanAtten Mary
LandOfFree
N-ureidoalkyl-piperidines as modulators of chemokine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-ureidoalkyl-piperidines as modulators of chemokine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-ureidoalkyl-piperidines as modulators of chemokine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3408318